CV Information
DR. TENGKU AHMAD DAMITRI AL-ASTANI
| |
---|---|
Grant's Name,"Project's Title" (Research Period)(Role)[Sponsorship]
| |
1 | GRADUATE DEVELOPMENT INCENTIVE - PHD, "IDENTIFICATION OF MIRNAS AS POTENTIAL BIOMARKERS FOR EARLY DETECTION OF BREAST CANCER PATIENT AT HOSPITAL UNIVERSITI SAINS MALAYSIA (HOSPITAL USM)" (01.07.2021 - 30.06.2023) (Principal) [ TABUNG PPSP ] - Source: eR&I |
2 | GRADUATE DEVELOPMENT INCENTIVE - PHD, "UNDERSTANDING THE ASSOCIATION BETWEEN GENETIC POLYMORPHISM OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) AND INSULIN-LIKE FACTOR BINDING PROTEIN-3 (IGFBP-3) WITH SERUM LECELS (IGFBP3) AMONG PALESTINIAN BREAST CANCER WOMEN IN GAZA STRIP" (01.12.2020 - 30.11.2022) (Principal) [ TABUNG PPSP ] - Source: eR&I |
3 | RESEARCH UNIVERSITY (INDIVIDUAL), "ELUCIDATING METABOLOMIC PROFILES OF BREAST CANCER ANIMAL MODEL TREATED WITH SUNITINIB IN ASSOCIATION WITH ER, PR, & HER2 EXPRESSIONS" (01.09.2020 - 31.08.2023) (Principal) [ USM (RU) ] - Source: eR&I |
4 | RESEARCH UNIVERSITY (INDIVIDUAL), "ELUCIDATING THE EFFECTS OF SIROLIMUS (ANTI-MTOR) AND SUNITINIB (ANTI-VEGF) ON MCF-7 BREAST CANCER CELL LINE AND XENOGRAFT MOUSE MODEL" (01.10.2017 - 30.09.2020) (Principal) [ USM (RU) ] - Source: eR&I |
5 | SHORT TERM - ACADEMIC STAFF, "IN VITRO STUDY OF THE EFFECTS OF ANDROGRAPHOLIDES ON GROWTH OF BREAST CANCER CELL LINES" (01.09.2014 - 31.08.2016) (Principal) [ USM (JANGKA PENDEK) ] - Source: eR&I |
6 | SHORT TERM - ACADEMIC STAFF, "THE EFFECTS OF RAPAMYCIN ON CELL APOPTOSIS ACTIVITIES OF HUMAN BREAST CANCER CELL LINES (MCF-7 & MDAMB231)" (01.05.2010 - 30.04.2012) (Principal) [ USM (JANGKA PENDEK) ] - Source: eR&I |
7 | , "BREAST CANCER RISK ASSOCIATED WITH ENDOCRINE DISRUPTORS, PERFLUOROALKYL AND POLYFLUOROALKYL SUBSTANCES (PFAS) AND TRACE ELEMENTS IN THE MALAYSIAN WOMEN POPULATION IN KELANTAN." (01.07.2023 - 31.05.2025) [ USM ] - Source: HCMSv3 |
8 | , "IDENTIFICATION OF MIRNAS AS POTENTIAL BIOMARKERS FOR EARLY DETECTION OF BREAST CANCER PATIENT AT HOSPITAL USM" (25.09.2021 - 25.09.2021) [ USM ] - Source: HCMSv3 |